Navigation Links
Insulet Establishes Eco-Friendly Disposal Program for the OmniPod(R) Insulin Management System
Date:7/8/2009

BEDFORD, Mass., July 8 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in tubing-free insulin pump technology, announced today that the Company is introducing an environmentally friendly disposal program for its OmniPod(R) Insulin Management System. The Eco-Pod program will reduce the impact of used Pods on the environment, preventing hazardous waste from unnecessarily entering landfills. It is the industry's first program for the environmentally safe disposal of insulin pump components.

"People with diabetes shouldn't have to choose between taking care of their health and taking care of the environment," said Duane DeSisto, president & chief executive officer of Insulet. "We are proud to offer our customers the first environmentally safe disposal program in the insulin pump industry. The OmniPod System makes diabetes a smaller part of life and now it will have a smaller impact on the environment."

The Eco-Pod Program provides OmniPod customers an easy way to reduce their impact on the environment. Following procedures for bio-hazardous waste, the Pods are disassembled and metals are removed and recycled. The remaining components are then pulverized. The process takes hazardous waste that might leach into the ground water out of the waste stream; it also greatly reduces the volume of materials that are consigned to a landfill.

To participate, customers simply log on to MyOmniPod.com to pre-register. Insulet will pay for the costs associated with the disposal process, while program participants are responsible for shipping costs, which are less than $3 per month. Beginning August 1, a Pod Disposal Kit will be included with each Pod re-order. The kit includes all the tools customers need to do their part: a bag for collecting used Pods, a special pre-paid, pre-addressed bio-hazard shipping envelope and an instruction sheet. Every three months, participating customers return their used Pods in the shipping envelope. The first 2,000 customers to enroll in the Eco-Pod program will receive a free, limited-edition eco-friendly tote bag.

About the OmniPod Insulin Management System

The OmniPod Insulin Management System is the world's only tubing-free insulin pump. OmniPod offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease. OmniPod has just two components: the small, discreet, watertight Pod, worn almost anywhere on the body to hold and deliver insulin; and the PDM (Personal Diabetes Manager), a hand-held device that communicates wirelessly to program the Pod, calculates suggested doses and has a built-in FreeStyle(R) blood glucose meter.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contact:
    Darcy Keane, Lazar Partners for Insulet Corporation
    Tel. 646-871-8487
    E-mail: dkeane@lazarpartners.com


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Applauds Employee for Bronze Medal Performance in World Blind Sailing Championships
2. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
3. Insulet Corporation to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009
4. Insulet Receives $60 Million Funding Commitment
5. Insulet Reports Fourth Quarter and Year End 2008 Results
6. Insulet Corporation to Report Fourth Quarter and Full Year 2008 Financial Results on Thursday, March 5, 2009
7. Insulet Corporation to Present at the J.P. Morgan Healthcare Conference on January 14, 2009
8. Insulet Reports Third Quarter 2008 Results
9. Insulet Announces Sponsorship of International Diabetes Federations World Diabetes Day Campaign
10. Sally W. Crawford Joins Insulets Board of Directors
11. Insulet Corporation to Report Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
Breaking Medicine Technology: